This report contains market size and forecasts of Oncolytic Virus Immunotherapy in Global, including the following market information:
Global Oncolytic Virus Immunotherapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Oncolytic Virus Immunotherapy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Oncolytic Virus Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncolytic Virus Immunotherapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Oncolytic Virus Immunotherapy Market Segment Percentages, By Type, 2020 (%)
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
China Oncolytic Virus Immunotherapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Oncolytic Virus Immunotherapy Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Global Oncolytic Virus Immunotherapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Oncolytic Virus Immunotherapy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Oncolytic Virus Immunotherapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Oncolytic Virus Immunotherapy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Oncolytic Virus Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncolytic Virus Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncolytic Virus Immunotherapy Overall Market Size
2.1 Global Oncolytic Virus Immunotherapy Market Size: 2021 VS 2027
2.2 Global Oncolytic Virus Immunotherapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncolytic Virus Immunotherapy Players in Global Market
3.2 Top Global Oncolytic Virus Immunotherapy Companies Ranked by Revenue
3.3 Global Oncolytic Virus Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Oncolytic Virus Immunotherapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Oncolytic Virus Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncolytic Virus Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Oncolytic Virus Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncolytic Virus Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncolytic Virus Immunotherapy Market Size Markets, 2021 & 2027
4.1.2 Engineering Oncolytic Viruses
4.1.3 Wild-Type Oncolytic Viruses
4.2 By Type - Global Oncolytic Virus Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Oncolytic Virus Immunotherapy Revenue, 2016-2021
4.2.2 By Type - Global Oncolytic Virus Immunotherapy Revenue, 2022-2027
4.2.3 By Type - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncolytic Virus Immunotherapy Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.2 By Application - Global Oncolytic Virus Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Oncolytic Virus Immunotherapy Revenue, 2016-2021
5.2.2 By Application - Global Oncolytic Virus Immunotherapy Revenue, 2022-2027
5.2.3 By Application - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Oncolytic Virus Immunotherapy Market Size, 2021 & 2027
6.2 By Region - Global Oncolytic Virus Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Oncolytic Virus Immunotherapy Revenue, 2016-2021
6.2.2 By Region - Global Oncolytic Virus Immunotherapy Revenue, 2022-2027
6.2.3 By Region - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Oncolytic Virus Immunotherapy Revenue, 2016-2027
6.3.2 US Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.3.3 Canada Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.3.4 Mexico Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Oncolytic Virus Immunotherapy Revenue, 2016-2027
6.4.2 Germany Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.4.3 France Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.4.4 U.K. Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.4.5 Italy Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.4.6 Russia Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.4.7 Nordic Countries Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.4.8 Benelux Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Oncolytic Virus Immunotherapy Revenue, 2016-2027
6.5.2 China Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.5.3 Japan Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.5.4 South Korea Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.5.5 Southeast Asia Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.5.6 India Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Oncolytic Virus Immunotherapy Revenue, 2016-2027
6.6.2 Brazil Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.6.3 Argentina Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue, 2016-2027
6.7.2 Turkey Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.7.3 Israel Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.7.4 Saudi Arabia Oncolytic Virus Immunotherapy Market Size, 2016-2027
6.7.5 UAE Oncolytic Virus Immunotherapy Market Size, 2016-2027
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Oncolytic Virus Immunotherapy Major Product Offerings
7.1.4 Merck Oncolytic Virus Immunotherapy Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Oncolytic Virus Immunotherapy Major Product Offerings
7.2.4 Amgen Oncolytic Virus Immunotherapy Revenue in Global (2016-2021)
7.2.5 Amgen Key News
7.3 TILT Biotherapeutics
7.3.1 TILT Biotherapeutics Corporate Summary
7.3.2 TILT Biotherapeutics Business Overview
7.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Major Product Offerings
7.3.4 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue in Global (2016-2021)
7.3.5 TILT Biotherapeutics Key News
7.4 Oncorus
7.4.1 Oncorus Corporate Summary
7.4.2 Oncorus Business Overview
7.4.3 Oncorus Oncolytic Virus Immunotherapy Major Product Offerings
7.4.4 Oncorus Oncolytic Virus Immunotherapy Revenue in Global (2016-2021)
7.4.5 Oncorus Key News
7.5 Sorrento Therapeutics
7.5.1 Sorrento Therapeutics Corporate Summary
7.5.2 Sorrento Therapeutics Business Overview
7.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Major Product Offerings
7.5.4 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue in Global (2016-2021)
7.5.5 Sorrento Therapeutics Key News
7.6 Shanghai Sunway Biotech
7.6.1 Shanghai Sunway Biotech Corporate Summary
7.6.2 Shanghai Sunway Biotech Business Overview
7.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Major Product Offerings
7.6.4 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue in Global (2016-2021)
7.6.5 Shanghai Sunway Biotech Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Oncolytic Virus Immunotherapy Market Opportunities & Trends in Global Market
Table 2. Oncolytic Virus Immunotherapy Market Drivers in Global Market
Table 3. Oncolytic Virus Immunotherapy Market Restraints in Global Market
Table 4. Key Players of Oncolytic Virus Immunotherapy in Global Market
Table 5. Top Oncolytic Virus Immunotherapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Oncolytic Virus Immunotherapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Oncolytic Virus Immunotherapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Oncolytic Virus Immunotherapy Product Type
Table 9. List of Global Tier 1 Oncolytic Virus Immunotherapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncolytic Virus Immunotherapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Oncolytic Virus Immunotherapy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Oncolytic Virus Immunotherapy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Oncolytic Virus Immunotherapy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 30. Merck Corporate Summary
Table 31. Merck Oncolytic Virus Immunotherapy Product Offerings
Table 32. Merck Oncolytic Virus Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 33. Amgen Corporate Summary
Table 34. Amgen Oncolytic Virus Immunotherapy Product Offerings
Table 35. Amgen Oncolytic Virus Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 36. TILT Biotherapeutics Corporate Summary
Table 37. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product Offerings
Table 38. TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 39. Oncorus Corporate Summary
Table 40. Oncorus Oncolytic Virus Immunotherapy Product Offerings
Table 41. Oncorus Oncolytic Virus Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 42. Sorrento Therapeutics Corporate Summary
Table 43. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product Offerings
Table 44. Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 45. Shanghai Sunway Biotech Corporate Summary
Table 46. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product Offerings
Table 47. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Oncolytic Virus Immunotherapy Segment by Type
Figure 2. Oncolytic Virus Immunotherapy Segment by Application
Figure 3. Global Oncolytic Virus Immunotherapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oncolytic Virus Immunotherapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Oncolytic Virus Immunotherapy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2020
Figure 8. By Type - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
Figure 12. US Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
Figure 16. Germany Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 17. France Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
Figure 24. China Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 28. India Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
Figure 30. Brazil Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Oncolytic Virus Immunotherapy Revenue Market Share, 2016-2027
Figure 33. Turkey Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Oncolytic Virus Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 37. Merck Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Amgen Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Oncorus Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech